, a California-based biotech company backed by Tako Ventures, has shelved plans to float, citing concerns over “market conditions”. The IPO was ooking to raise around US$80m.
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case
it’s been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.